Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier de Leval

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Mini Reviews in Medicinal Chemistry|July 29, 2004
Recent development in the field of dual COX / 5-LOX inhibitorsFabien Julémont, Jean-Michel Dogné, Bernard Pirotte, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 23, 2006
The use of nimesulide and its analogues in cancer chemopreventionJean-Fran Ois Renard, Fabien Julémont, Xavier de Leval, et al.
Journal of Medicinal Chemistry|October 2, 2009
Pyridine analogues of nimesulide: design, synthesis, and in vitro and in vivo pharmacological evaluation as promising cyclooxygenase 1 and 2 inhibitorsJean-François Renard, Deniz Arslan, Nancy Garbacki, et al.
European Journal of Medicinal Chemistry|January 21, 2014
N-(3-Arylaminopyridin-4-yl)alkanesulfonamides as pyridine analogs of nimesulide: cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolismJean-François Renard, Frédéric Lecomte, Philippe Hubert, et al.
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Thromboxane A2 inhibition: therapeutic potential in bronchial asthmaJean-Michel Dogné, Xavier de Leval, Patricia Benoit, et al.
Current Medicinal Chemistry|April 23, 2002
New trends in dual 5-LOX/COX inhibitionXavier de Leval, Fabien Julemont, Jacques Delarge, et al.
Mini Reviews in Medicinal Chemistry|July 29, 2004
First and second generations of COX-2 selective inhibitorsXavier de Leval, Fabien Julémont, Valérie Benoit, et al.
Expert Opinion on Investigational Drugs|February 7, 2002
Therapeutic potential of thromboxane inhibitors in asthmaJean-Michel Dogné, Xavier de Leval, Patricia Benoit, et al.
Mini Reviews in Medicinal Chemistry|July 29, 2004
Modulation of the arachidonic cascade with omega3 fatty acids or analogues: potential therapeutic benefitsIsabelle Roland, Xavier De Leval, Brigitte Evrard, et al.
European Urology|March 9, 2006
Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stageThibaut Dassesse, Xavier de Leval, Laurence de Leval, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Mini Reviews in Medicinal Chemistry|July 29, 2004
Recent development in the field of dual COX / 5-LOX inhibitorsFabien Julémont, Jean-Michel Dogné, Bernard Pirotte, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 23, 2006
The use of nimesulide and its analogues in cancer chemopreventionJean-Fran Ois Renard, Fabien Julémont, Xavier de Leval, et al.
Journal of Medicinal Chemistry|October 2, 2009
Pyridine analogues of nimesulide: design, synthesis, and in vitro and in vivo pharmacological evaluation as promising cyclooxygenase 1 and 2 inhibitorsJean-François Renard, Deniz Arslan, Nancy Garbacki, et al.
European Journal of Medicinal Chemistry|January 21, 2014
N-(3-Arylaminopyridin-4-yl)alkanesulfonamides as pyridine analogs of nimesulide: cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolismJean-François Renard, Frédéric Lecomte, Philippe Hubert, et al.
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Thromboxane A2 inhibition: therapeutic potential in bronchial asthmaJean-Michel Dogné, Xavier de Leval, Patricia Benoit, et al.
Current Medicinal Chemistry|April 23, 2002
New trends in dual 5-LOX/COX inhibitionXavier de Leval, Fabien Julemont, Jacques Delarge, et al.
Mini Reviews in Medicinal Chemistry|July 29, 2004
First and second generations of COX-2 selective inhibitorsXavier de Leval, Fabien Julémont, Valérie Benoit, et al.
Expert Opinion on Investigational Drugs|February 7, 2002
Therapeutic potential of thromboxane inhibitors in asthmaJean-Michel Dogné, Xavier de Leval, Patricia Benoit, et al.
Mini Reviews in Medicinal Chemistry|July 29, 2004
Modulation of the arachidonic cascade with omega3 fatty acids or analogues: potential therapeutic benefitsIsabelle Roland, Xavier De Leval, Brigitte Evrard, et al.
European Urology|March 9, 2006
Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stageThibaut Dassesse, Xavier de Leval, Laurence de Leval, et al.
Pageof 3